FIELD: medicine, virology, pharmaceutical industry, pharmacy.
SUBSTANCE: invention proposes using drug fucoidan as an agent possessing antiviral activity with respect to Hantaan virus representing pathogen of hemorrhagic fever with renal syndrome. Fucoidan possesses high antiviral activity with respect to Hantaan virus representing a pathogen of hemorrhagic fever with renal syndrome. Invention can be used as an agent against Hantaan virus representing a pathogen of hemorrhagic fever with renal syndrome.
EFFECT: valuable property of agent.
4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| FENCHONE N-ACYLHYDRAZONE WITH AN EPOXY ISOINDOLE FRAGMENT USED AS AN INHIBITOR OF HANTAAN VIRUS REPRODUCTION | 2020 |
|
RU2733472C1 |
| ANTIVIRAL MEDICATION AND METHOD OF PREVENTION AND TREATMENT OF VIRAL INFECTIONS | 2010 |
|
RU2457844C2 |
| BIOLOGICALLY ACTIVE PRODUCT FROM BROWN ALGAE, BIOLOGICALLY ACTIVE FOOD SUPPLEMENT, SOFT DRINK, PERFUME AND COSMETIC AGENT | 2006 |
|
RU2315487C1 |
| ANIMAL MODELING OF HEMORRHAGIC NEPHROSONEPHRITIS DISEASE CAUSED BY HANTAAN VIRUS | 2005 |
|
RU2294563C2 |
| AGENT INDUCING MATURING OF DENDRITIC CELLS | 2008 |
|
RU2361598C1 |
| METHOD FOR PREPARING COMBINED BIVALENT, TISSUE-CULTURE, INACTIVATED, CONCENTRATED, PURIFIED VACCINE FOR PREVENTING HEMORRHAGIC FEVER AND RENAL SYNDROME | 2009 |
|
RU2445117C2 |
| VIRUS STRAIN FOR PRODUCING VACCINE DRUGS AGAINST HEMORRHAGIC FEVER WITH RENAL SYNDROME (OPTIONS) | 2018 |
|
RU2683508C1 |
| METHOD OF PRODUCTION OF RECOMBINANT ANTIGEN G2 OF HANTAVIRUS DOBRAVA IN CELLS OF E coli | 2011 |
|
RU2495938C2 |
| AGENT ELICITING ANTICOAGULATING AND IMMUNOTROPIC EFFECT | 2002 |
|
RU2247574C2 |
| METHOD OF OBTAINING IMMUNOENZYMATIC TEST SYSTEM FOR DETERMINATION OF EPITOPES OF ENVELOPE PROTEIN OF PUUMALA VIRUS WITH PROTECTIVE ORIENTATION IN VACCINE PREPARATIONS AGAINST HAEMORRHAGIC FEVER WITH RENAL SYNDROME | 2013 |
|
RU2565543C2 |
